Novel pyrrol-2(3H)-ones and pyridazin-3(2H)-ones carrying quinoline scaffold as anti-proliferative tubulin polymerization inhibitors
- PMID: 29920422
- DOI: 10.1016/j.bioorg.2018.06.003
Novel pyrrol-2(3H)-ones and pyridazin-3(2H)-ones carrying quinoline scaffold as anti-proliferative tubulin polymerization inhibitors
Abstract
A novel quinolinyl pyrrolone and quinolinyl pyridazinone derivatives has been synthesized and characterized using different spectroscopic and elemental analysis techniques. Most of the target compounds displayed promising antiproliferative activity; In general, the pyrrolone derivatives 4a-f exhibited higher antiproliferative activity than their corresponding pyridazinone. The pyrrolone 4f showed outstanding antiproliferative activity with moderate selectivity against CNS and renal cancer with selectivity ratio of 3.49 and 3.56, respectively. Compound 4e and 5d experienced tubulin polymerization inhibitory activity comparable to that of vincristine while 4c, 4e and 4d showed good BRAF kinase inhibition compared to Erlotinib. Docking of compound 4e into colchicine binding site and biological assay results revealed that these compounds act mainly through tubulin polymerization inhibitory mechanism and can exhibit pre G1 apoptosis and cell cycle arrest at G2/M phase.
Keywords: Antiproliferative; BRAF Kinase; Pyridazin-3(2H)-ones; Pyrrol-2(3H)-ones; Quinoline; Tubulin polymerization.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Design, synthesis, and biological evaluation of new series of pyrrol-2(3H)-one and pyridazin-3(2H)-one derivatives as tubulin polymerization inhibitors.Bioorg Chem. 2021 Feb;107:104522. doi: 10.1016/j.bioorg.2020.104522. Epub 2020 Dec 1. Bioorg Chem. 2021. PMID: 33317838
-
Synthesis, cytotoxic activity, and tubulin polymerization inhibitory activity of new pyrrol-2(3H)-ones and pyridazin-3(2H)-ones.Bioorg Chem. 2016 Jun;66:46-62. doi: 10.1016/j.bioorg.2016.03.007. Epub 2016 Mar 15. Bioorg Chem. 2016. PMID: 27016713
-
Design, synthesis and biological evaluation of millepachine derivatives as a new class of tubulin polymerization inhibitors.Bioorg Med Chem. 2013 Nov 1;21(21):6844-54. doi: 10.1016/j.bmc.2013.02.002. Epub 2013 Feb 13. Bioorg Med Chem. 2013. PMID: 23993668
-
Tubulin Inhibitors Binding to Colchicine-Site: A Review from 2015 to 2019.Curr Med Chem. 2020;27(40):6787-6814. doi: 10.2174/0929867326666191003154051. Curr Med Chem. 2020. PMID: 31580244 Review.
-
Progress of tubulin polymerization activity detection methods.Bioorg Med Chem Lett. 2021 Apr 1;37:127698. doi: 10.1016/j.bmcl.2020.127698. Epub 2021 Jan 16. Bioorg Med Chem Lett. 2021. PMID: 33468346 Review.
Cited by
-
A Review of the Recent Developments of Molecular Hybrids Targeting Tubulin Polymerization.Int J Mol Sci. 2022 Apr 4;23(7):4001. doi: 10.3390/ijms23074001. Int J Mol Sci. 2022. PMID: 35409361 Free PMC article. Review.
-
An updated literature on BRAF inhibitors (2018-2023).Mol Divers. 2024 Aug;28(4):2689-2730. doi: 10.1007/s11030-023-10699-3. Epub 2023 Jul 20. Mol Divers. 2024. PMID: 37470921 Review.
-
Exploring Three Avenues: Chemo- and Regioselective Transformations of 1,2,4-Triketone Analogs into Pyrazoles and Pyridazinones.Int J Mol Sci. 2023 Sep 18;24(18):14234. doi: 10.3390/ijms241814234. Int J Mol Sci. 2023. PMID: 37762539 Free PMC article.
-
Design, synthesis, in silico studies, and apoptotic antiproliferative activity of novel thiazole-2-acetamide derivatives as tubulin polymerization inhibitors.Front Chem. 2025 Apr 16;13:1565699. doi: 10.3389/fchem.2025.1565699. eCollection 2025. Front Chem. 2025. PMID: 40308265 Free PMC article.
-
Molecular targets and anticancer activity of quinoline-chalcone hybrids: literature review.RSC Adv. 2020 Aug 21;10(52):31139-31155. doi: 10.1039/d0ra05594h. eCollection 2020 Aug 21. RSC Adv. 2020. PMID: 35520674 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials